Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2022

December 2017 | 107 pages | ID: G746626CBE0EN
QYResearch

Abstracts

This report studies the global Musculoskeletal Disorders Therapeutics market, analyzes and researches the Musculoskeletal Disorders Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Pfizer
• AbbVie
• Johnson & Johnson
• Sanofi
• Merck
• Novartis
• Eli Lilly
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• Amgen
• Takeda Pharmaceutical
• Daiichi Sankyo
• LG Life Sciences
• Astellas
• Samsung Bioepis
• Zosano Pharma
• Taisho Pharmaceutical
• 3SBio

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Biologics
• Small Molecules
• Other

Market segment by Application, Musculoskeletal Disorders Therapeutics can be split into

• Osteoarthritis
• Osteoporosis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Fibromyalgia
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF MUSCULOSKELETAL DISORDERS THERAPEUTICS

1.1 Musculoskeletal Disorders Therapeutics Market Overview
  1.1.1 Musculoskeletal Disorders Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Musculoskeletal Disorders Therapeutics Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Musculoskeletal Disorders Therapeutics Market by Type
  1.3.1 Biologics
  1.3.2 Small Molecules
  1.3.3 Other
1.4 Musculoskeletal Disorders Therapeutics Market by End Users/Application
  1.4.1 Osteoarthritis
  1.4.2 Osteoporosis
  1.4.3 Psoriatic Arthritis
  1.4.4 Ankylosing Spondylitis
  1.4.5 Fibromyalgia
  1.4.6 Other

2 GLOBAL MUSCULOSKELETAL DISORDERS THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Musculoskeletal Disorders Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 AbbVie
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Johnson & Johnson
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Sanofi
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Merck
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novartis
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Eli Lilly
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 AstraZeneca
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Boehringer Ingelheim
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 F. Hoffmann-La Roche
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Amgen
3.12 Takeda Pharmaceutical
3.13 Daiichi Sankyo
3.14 LG Life Sciences
3.15 Astellas
3.16 Samsung Bioepis
3.17 Zosano Pharma
3.18 Taisho Pharmaceutical
3.19 3SBio

4 GLOBAL MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Type (2012-2017)
4.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Musculoskeletal Disorders Therapeutics in Future
4.4 Top Consumer/End Users of Musculoskeletal Disorders Therapeutics

5 UNITED STATES MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
5.2 United States Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
6.2 EU Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 JAPAN MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
7.2 Japan Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 CHINA MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
8.2 China Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 INDIA MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
9.2 India Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA MUSCULOSKELETAL DISORDERS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Musculoskeletal Disorders Therapeutics Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.2 EU Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.4 China Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.5 India Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Musculoskeletal Disorders Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

12 MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET DYNAMICS

12.1 Musculoskeletal Disorders Therapeutics Market Opportunities
12.2 Musculoskeletal Disorders Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Musculoskeletal Disorders Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Musculoskeletal Disorders Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Musculoskeletal Disorders Therapeutics Product Scope
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) (2012-2017)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Regions in 2016
Figure United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Type in 2016
Figure Biologics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Small Molecules Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Osteoarthritis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Osteoarthritis (2012-2017)
Table Key Downstream Customer in Osteoporosis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Osteoporosis (2012-2017)
Table Key Downstream Customer in Psoriatic Arthritis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Psoriatic Arthritis (2012-2017)
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Ankylosing Spondylitis (2012-2017)
Table Key Downstream Customer in Fibromyalgia
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Fibromyalgia (2012-2017)
Table Key Downstream Customer in Other
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Takeda Pharmaceutical Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical (2012-2017)
Figure Takeda Pharmaceutical Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table LG Life Sciences Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of LG Life Sciences (2012-2017)
Figure LG Life Sciences Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Astellas Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Astellas (2012-2017)
Figure Astellas Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Samsung Bioepis Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Samsung Bioepis (2012-2017)
Figure Samsung Bioepis Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Zosano Pharma Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Zosano Pharma (2012-2017)
Figure Zosano Pharma Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Taisho Pharmaceutical Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Taisho Pharmaceutical (2012-2017)
Figure Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table 3SBio Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of 3SBio (2012-2017)
Figure 3SBio Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2012
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2013
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2014
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2015
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2016
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2017
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Musculoskeletal Disorders Therapeutics
Figure United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure United States Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure EU Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Japan Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure China Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure China Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure India Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure India Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions in 2022
Figure United States Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2022
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2022